Trastuzumab is used in the treatment of a particular type of breast cancer -- HER2-positive, and the company markets its version in India under the brand name 'Trumab'. It is now priced at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/brmOQh3
via IFTTT
0 comments:
Post a Comment